This study aimed to explore the feasibility of using habitat radiomics based on magnetic resonance imaging (MRI) to predict metachronous liver metastasis (MLM) in locally advanced rectal cancer (LARC) patients. A nomogram was developed by integrating multiple factors to enhance predictive accuracy. Retrospective data from 385 LARC patients across two centers were gathered. The data from Center 1 were split into a training set of 203 patients and an internal validation set of 87 patients, while Center 2 provided an external test set of 95 patients. K - means clustering was used on T2 - weighted images, and the region of interest was extended at different thicknesses. After feature extraction and selection, four machine - learning algorithms were utilized to build radiomics models. A nomogram was created by combining habitat radiomics, conventional radiomics, and clinical independent predictors. Model performance was evaluated by the AUC, and clinical utility was assessed through calibration curve and DCA. Habitat radiomics outperformed other single models in predicting MLM, with AUCs of 0.926, 0.864, and 0.851 in respective sets. The integrated nomogram achieved even higher AUCs of 0.959, 0.925, and 0.889. DCA and calibration curve analysis showed its high net benefit and good calibration. MRI - based habitat radiomics can effectively predict MLM in LARC patients. The integrated nomogram has optimal predictive performance and improves model accuracy significantly.

The objective of this study was to evaluate a combination of deep learning (DL)-reconstructed parallel acquisition technique (PAT) and simultaneous multislice (SMS) acceleration imaging in comparison to conventional knee imaging. Adults undergoing knee magnetic resonance imaging (MRI) with DL-enhanced acquisitions were prospectively analyzed from December 2023 to April 2024. The participants received T1 without fat saturation and fat-suppressed PD-weighted TSE pulse sequences using conventional two-fold PAT (P2) and either DL-enhanced four-fold PAT (P4) or a combination of DL-enhanced four-fold PAT with two-fold SMS acceleration (P4S2). Three independent readers assessed image quality, signal-to-noise ratio (SNR), contrast-to-noise ratio (CNR), and radiomics features. 34 participants (mean age 45±17years; 14 women) were included who underwent P4S2, P4, and P2 imaging. Both P4S2 and P4 demonstrated higher CNR and SNR values compared to P2 (P<.001). P4 was diagnostically inferior to P2 only in the visualization of cartilage damage (P<.005), while P4S2 consistently outperformed P2 in anatomical delineation across all evaluated structures and raters (P<.05). Radiomics analysis revealed significant differences in contrast and gray-level characteristics among P2, P4, and P4S2 (P<.05). P4 reduced time by 31% and P4S2 by 41% compared to P2 (P<.05). P4S2 DL acceleration offers significant advancements over P4 and P2 in knee MRI, combining superior image quality and improved anatomical delineation at significant time reduction. Its improvements in anatomical delineation, energy consumption, and workforce optimization make P4S2 a significant step forward.

Current anomaly detection methods excel with benchmark industrial data but struggle with natural images and medical data due to varying definitions of 'normal' and 'abnormal.' This makes accurate identification of deviations in these fields particularly challenging. Especially for 3D brain MRI data, all the state-of-the-art models are reconstruction-based with 3D convolutional neural networks which are memory-intensive, time-consuming and producing noisy outputs that require further post-processing. We propose a framework called Simple Slice-based Network (SimpleSliceNet), which utilizes a model pre-trained on ImageNet and fine-tuned on a separate MRI dataset as a 2D slice feature extractor to reduce computational cost. We aggregate the extracted features to perform anomaly detection tasks on 3D brain MRI volumes. Our model integrates a conditional normalizing flow to calculate log likelihood of features and employs the contrastive loss to enhance anomaly detection accuracy. The results indicate improved performance, showcasing our model's remarkable adaptability and effectiveness when addressing the challenges exists in brain MRI data. In addition, for the large-scale 3D brain volumes, our model SimpleSliceNet outperforms the state-of-the-art 2D and 3D models in terms of accuracy, memory usage and time consumption. Code is available at: https://github.com/Jarvisarmy/SimpleSliceNet.

Two of the most common complaints seen in neurology clinics are Alzheimer's disease (AD) and mild cognitive impairment (MCI), characterized by similar symptoms. The aim of this study was to develop and internally validate the diagnostic value of combined neurological and radiological predictors in differentiating mild AD from MCI as the outcome variable, which helps in preventing AD development. A cross-sectional study of 161 participants was conducted in a general healthcare setting, including 30 controls, 71 mild AD, and 60 MCI. Binary logistic regression was used to identify predictors of interest, with collinearity assessment conducted prior to model development. Model performance was assessed through calibration, shrinkage, and decision-curve analyses. Finally, the combined clinical and radiological model was compared to models utilizing only clinical or radiological predictors. The final model included age, sex, education status, Montreal cognitive assessment, Global Cerebral Atrophy Index, Medial Temporal Atrophy Scale, mean hippocampal volume, and Posterior Parietal Atrophy Index, with the area under the curve of 0.978 (0.934-0.996). Internal validation methods did not show substantial reduction in diagnostic performance. Combined model showed higher diagnostic performance compared to clinical and radiological models alone. Decision curve analysis highlighted the usefulness of this model for differentiation across all probability levels. A combined clinical-radiological model has excellent diagnostic performance in differentiating mild AD from MCI. Notably, the model leveraged straightforward neuroimaging markers, which are relatively simple to measure and interpret, suggesting that they could be integrated into practical, formula-driven diagnostic workflows without requiring computationally intensive deep learning models.

Eating disorders (EDs), including anorexia nervosa (AN), bulimia nervosa (BN), and binge eating disorder (BED), are complex psychiatric conditions with high morbidity and mortality. Neuroimaging and machine learning (ML) represent promising approaches to improve diagnosis, understand pathophysiological mechanisms, and predict treatment response. This systematic review aimed to evaluate the application of ML techniques to neuroimaging data in EDs. Following PRISMA guidelines (PROSPERO registration: CRD42024628157), we systematically searched PubMed and APA PsycINFO for studies published between 2014 and 2024. Inclusion criteria encompassed human studies using neuroimaging and ML methods applied to AN, BN, or BED. Data extraction focused on study design, imaging modalities, ML techniques, and performance metrics. Quality was assessed using the GRADE framework and the ROBINS-I tool. Out of 185 records screened, 5 studies met the inclusion criteria. Most applied support vector machines (SVMs) or other supervised ML models to structural MRI or diffusion tensor imaging data. Cortical thickness alterations in AN and diffusion-based metrics effectively distinguished ED subtypes. However, all studies were observational, heterogeneous, and at moderate to serious risk of bias. Sample sizes were small, and external validation was lacking. ML applied to neuroimaging shows potential for improving ED characterization and outcome prediction. Nevertheless, methodological limitations restrict generalizability. Future research should focus on larger, multicenter, and multimodal studies to enhance clinical applicability. Level IV, multiple observational studies with methodological heterogeneity and moderate to serious risk of bias.

To study the feasibility of multiple factors in improving the diagnostic accuracy of clinically significant prostate cancer (csPCa). A retrospective study with 131 patients analyzes age, PSA, PHI and pathology. Patients with ISUP > 2 were classified as csPCa, and others are non-csPCa. The mpMRI images were processed by a homemade AI algorithm, obtaining positive or negative AI results. Four logistic regression models were fitted, with pathological findings as the dependent variable. The predicted probability of the patients was used to test the prediction efficacy of the models. The DeLong test was performed to compare differences in the area under the receiver operating characteristic (ROC) curves (AUCs) between the models. The study includes 131 patients: 62 were diagnosed with csPCa and 69 were non-csPCa. Statically significant differences were found in age, PSA, PIRADS score, AI results, and PHI values between the 2 groups (all P ≤ 0.001). The conventional model (R² = 0.389), the AI model (R² = 0.566), and the PHI model (R² = 0.515) were compared to the full model (R² = 0.626) with ANOVA and showed statistically significant differences (all P < 0.05). The AUC of the full model (0.921 [95% CI: 0.871-0.972]) was significantly higher than that of the conventional model (P = 0.001), AI model (P < 0.001), and PHI model (P = 0.014). Combining multiple factors such as age, PSA, PIRADS score and PHI, adding AI algorithm based on mpMRI, the diagnostic accuracy of csPCa can be improved.

Proton resonance frequency (PRF)-based magnetic resonance (MR) thermometry plays a critical role in thermal ablation therapies through focused ultrasound (FUS). For clinical applications, accurate and rapid temperature feedback is essential to ensure both the safety and effectiveness of these treatments. This work aims to improve temporal resolution in dynamic MR temperature map reconstructions using an enhanced deep-learning method, thereby supporting the real-time monitoring required for effective FUS treatments. Five classical neural network architectures-cascade net, complex-valued U-Net, shift window transformer for MRI, real-valued U-Net, and U-Net with residual blocks-along with training-optimized methods were applied to reconstruct temperature maps from 2-fold and 4-fold undersampled k-space data. The training enhancements included pre-training/training-phase data augmentations, knowledge distillation, and a novel amplitude-phase decoupling loss function. Phantom and ex vivo tissue heating experiments were conducted using a FUS transducer. Ground truth was the complex MR images with accurate temperature changes, and datasets were manually undersampled to simulate such acceleration here. Separate testing datasets were used to evaluate real-time performance and temperature accuracy. Furthermore, our proposed deep learning-based rapid reconstruction approach was validated on a clinical dataset obtained from patients with uterine fibroids, demonstrating its clinical applicability. Acceleration factors of 1.9 and 3.7 were achieved for 2× and 4× k-space under samplings, respectively. The deep learning-based reconstruction using ResUNet incorporating the four optimizations, showed superior performance. For 2-fold acceleration, the RMSE of temperature map patches were 0.89°C and 1.15°C for the phantom and ex vivo testing datasets, respectively. The DICE coefficient for the 43°C isotherm-enclosed regions was 0.81, and the Bland-Altman analysis indicated a bias of -0.25°C with limits of agreement of ±2.16°C. In the 4-fold under-sampling case, these evaluation metrics showed approximately a 10% reduction in accuracy. Additionally, the DICE coefficient measuring the overlap between the reconstructed temperature maps (using the optimized ResUNet) and the ground truth, specifically in regions where the temperature exceeded the 43°C threshold, were 0.77 and 0.74 for the 2× and 4× under-sampling scenarios, respectively. This study demonstrates that deep learning-based reconstruction significantly enhances the accuracy and efficiency of MR thermometry, particularly in the context of FUS-based clinical treatments for uterine fibroids. This approach could also be extended to other applications such as essential tremor and prostate cancer treatments where MRI-guided FUS plays a critical role.

This paper presents MSLesSeg, a new, publicly accessible MRI dataset designed to advance research in Multiple Sclerosis (MS) lesion segmentation. The dataset comprises 115 scans of 75 patients including T1, T2 and FLAIR sequences, along with supplementary clinical data collected across different sources. Expert-validated annotations provide high-quality lesion segmentation labels, establishing a reliable human-labeled dataset for benchmarking. Part of the dataset was shared with expert scientists with the aim to compare the last automatic AI-based image segmentation solutions with an expert-biased handmade segmentation. In addition, an AI-based lesion segmentation of MSLesSeg was developed and technically validated against the last state-of-the-art methods. The dataset, the detailed analysis of researcher contributions, and the baseline results presented here mark a significant milestone for advancing automated MS lesion segmentation research.

Magnetic resonance imaging (MRI), combined with artificial intelligence techniques, has improved our understanding of brain structural change and enabled the estimation of brain age. Neurodegenerative disorders, such as Alzheimer's disease (AD), have been linked to accelerated brain aging. In this study, we aimed to develop a deep-learning framework that processes and integrates MRI images to more accurately predict brain age, cognitive function, and amyloid pathology. In this study, we aimed to develop a deep-learning framework that processes and integrates MRI images to more accurately predict brain age, cognitive function, and amyloid pathology.We collected over 10,000 T1-weighted MRI scans from more than 7,000 individuals across six cohorts. We designed a multi-modal deep-learning framework that employs 3D convolutional neural networks to analyze MRI and additional neural networks to evaluate demographic data. Our initial model focused on predicting brain age, serving as a foundational model from which we developed separate models for cognition function and amyloid plaque prediction through transfer learning. The brain age prediction model achieved the mean absolute error (MAE) for cognitive normal population in the ADNI (test) datasets of 3.302 years. The gap between predicted brain age and chronological age significantly increases while cognition declines. The cognition prediction model exhibited a root mean square error (RMSE) of 0.334 for the Clinical Dementia Rating (CDR) regression task, achieving an area under the curve (AUC) of approximately 0.95 in identifying ing dementia patients. Dementia related brain regions, such as the medial temporal lobe, were identified by our model. Finally, amyloid plaque prediction model was trained to predict amyloid plaque, and achieved an AUC about 0.8 for dementia patients. These findings indicate that the present predictive models can identify subtle changes in brain structure, enabling precise estimates of brain age, cognitive status, and amyloid pathology. Such models could facilitate the use of MRI as a non-invasive diagnostic tool for neurodegenerative diseases, including AD.

Detecting breast cancer early is of the utmost importance to effectively treat the millions of women afflicted by breast cancer worldwide every year. Although mammography is the primary imaging modality for screening breast cancer, there is an increasing interest in adding magnetic resonance imaging (MRI) to screening programmes, particularly for women at high risk. Recent guidelines by the European Society of Breast Imaging (EUSOBI) recommended breast MRI as a supplemental screening tool for women with dense breast tissue. However, acquiring and reading MRI scans requires significantly more time from expert radiologists. This highlights the need to develop new automated methods to detect cancer accurately using MRI and Artificial Intelligence (AI), which have the potential to support radiologists in breast MRI interpretation and classification and help detect cancer earlier. For this reason, the ODELIA consortium has made this multi-centre dataset publicly available to assist in developing AI tools for the detection of breast cancer on MRI.